$1.05
-0.035-3.21%
Last update: Nov 6, 10:29 AM
Allogene Therapeutics Inc
ALLONASDAQ
The average analyst price target for Allogene Therapeutics is $7.68, 628.0% above the current price. Of 18 analysts, 12 rate it Buy and 6 Hold. Targets range from $3.85 to $14. The latest change came on Apr 16, 2026, when JP Morgan upgraded Allogene Therapeutics from Underweight to Neutral.
Price Target Range — 11 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
